Market Outlook

By 2035, the U.S. Orthopedic Surgical Devices Market is expected to reach approximately USD 62.30 billion, expanding at a CAGR of 7.35% during the forecast period 2026–2035. The market was valued at approximately USD 30.65 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. orthopedic surgical devices industry is one of the largest and most procedure-intensive segments of the domestic medical device economy. It encompasses joint reconstruction implants, spinal surgery systems, trauma fixation devices, sports medicine products, arthroscopy equipment, extremity implants, orthobiologics, surgical power tools, navigation platforms, and robotic-assisted orthopedic technologies. Demand is supported by the country’s aging population, high prevalence of osteoarthritis, growing incidence of fragility fractures, rising participation in sports, persistent obesity-related joint degeneration, and continued expansion of elective orthopedic surgery capacity.

More than one-fifth of U.S. adults report physician-diagnosed arthritis, while approximately 33 million adults are affected by osteoarthritis. Disease prevalence rises sharply with age and exceeds half of adults aged 75 years and older. These demographic and epidemiological conditions provide a durable procedure base for knee replacement, hip replacement, spinal fusion, fracture fixation, shoulder reconstruction, arthroscopic repair, and foot and ankle surgery.

The American Joint Replacement Registry has accumulated data covering more than five million hip and knee procedures across hospitals, ambulatory surgery centers, and orthopedic practices in all 50 states. More than 700,000 total knee replacement procedures are performed annually in the United States, and combined primary hip and knee replacement volumes are expected to move toward two million procedures annually by the end of the decade. This expanding procedural base directly supports recurring demand for implants, instruments, bone cement, biologics, disposable accessories, navigation equipment, and revision systems.

The market is advancing beyond conventional metallic implants and manual instruments toward an integrated orthopedic surgery ecosystem built around robotic-assisted procedures, computer navigation, image-guided spine surgery, patient-specific planning, 3D-printed implants, minimally invasive instrumentation, smart operating room connectivity, and data-supported postoperative management. Procurement decisions are increasingly influenced by the complete cost of the surgical episode rather than implant price alone.

Products that can reduce operating-room time, improve implant positioning, limit inventory requirements, support outpatient discharge, decrease revision risk, and standardize results across surgeons are receiving greater attention from U.S. hospital value analysis committees. Manufacturers are consequently competing not only through implant design, but also through software, capital equipment, clinical support, surgeon education, service contracts, and procedural data.

The historical market expanded from approximately USD 22.90 billion in 2021 to USD 28.25 billion in 2024. Growth during this period was supported by the recovery of elective orthopedic procedures, normalization of hospital operating-room capacity, accelerated movement of joint replacement into outpatient settings, increased adoption of surgical robotics, and continued investment in spine, trauma, and sports medicine technologies.

In 2025, the market reached approximately USD 30.65 billion as health systems increased orthopedic procedure capacity and manufacturers introduced expanded robotic applications, personalized implants, advanced fixation systems, and digitally enabled surgical workflows. The market estimate incorporates implant revenue, surgical instruments, enabling technologies, capital equipment, biologics, recurring disposables, and procedure-linked accessories used in orthopedic surgical care.

 

Introduction

According to the U.S. Orthopedic Surgical Devices Market Report, the industry is shaped by a combination of large musculoskeletal disease prevalence, advanced surgical infrastructure, a mature orthopedic specialist network, high elective-procedure volumes, expanding outpatient reimbursement, and continuous device innovation.

Orthopedic care in the United States is highly device-dependent. Surgical treatment commonly requires permanent implants, fixation hardware, navigation systems, specialized instruments, power equipment, imaging support, biologic materials, and procedure-specific consumables. Unlike certain diagnostic device categories, orthopedic surgical device demand is closely linked to completed surgical procedures, creating a measurable connection between patient volumes and manufacturer revenue.

The market is not a single uniform implant category. It contains mature, high-volume products such as primary hip and knee implants; premium technologies such as surgical robotics and navigation; recurring consumables such as anchors, sutures, saw blades, burrs, and arthroscopy accessories; and complex products such as spinal deformity systems, expandable cages, revision implants, limb reconstruction devices, and orthobiologic materials.

Joint reconstruction remains the largest product category because of the scale of knee and hip replacement procedures. Spine represents another substantial value pool due to the complexity of implants, instrumentation, biologics, and navigation technologies used in fusion and deformity procedures. Trauma fixation provides recurring demand linked to fractures and emergency care, while sports medicine benefits from high arthroscopy volumes, younger patient populations, and the treatment of ligament, tendon, cartilage, and soft-tissue injuries.

The U.S. hospital system includes more than 6,000 hospitals, over 900,000 staffed beds, and approximately 35 million annual admissions. Hospitals remain essential for complex joint revision, spinal deformity, major trauma, orthopedic oncology, and medically complicated surgical cases. However, lower-acuity procedures are increasingly being performed in hospital outpatient departments and ambulatory surgery centers.

The outpatient shift is particularly important for total knee arthroplasty, total hip arthroplasty, partial knee replacement, shoulder arthroscopy, rotator cuff repair, anterior cruciate ligament reconstruction, hand surgery, and selected foot and ankle procedures. Improvements in anesthesia, blood-loss management, multimodal pain control, surgical technique, patient selection, and recovery protocols have enabled appropriately selected patients to leave the facility on the day of surgery or after a short observation period.

This shift is changing device purchasing behavior. Ambulatory surgery centers prioritize compact instrumentation, reduced sterilization burden, predictable procedure times, simplified implant trays, lower capital requirements, and dependable case-level economics. Hospital systems, by comparison, may prioritize enterprise standardization, comprehensive revision portfolios, trauma availability, robotic platform utilization, and interoperability across multiple sites.

From 2026 to 2035, one of the most important strategic themes will be the conversion of orthopedic surgery from an implant-centered market into a digitally enabled procedural platform market. Companies capable of connecting preoperative planning, imaging, implant selection, robotic execution, intraoperative data, postoperative recovery, and outcomes documentation will hold stronger competitive positions than manufacturers selling isolated implants.

The market will also become more differentiated by care setting. High-acuity hospitals will continue to require broad inventories and complex technology platforms, while ambulatory facilities will favor streamlined systems designed for high-throughput surgery. Manufacturers will therefore need flexible commercial models, including capital sales, leasing, usage-based pricing, implant commitments, managed inventory, and service contracts.

 

Key Market Drivers: What’s Fueling the U.S. Orthopedic Surgical Devices Market Boom?

The first major driver is the scale of musculoskeletal disease burden in the United States. Arthritis affects tens of millions of adults and represents one of the most important causes of pain, physical limitation, reduced workforce participation, and disability. Osteoarthritis is especially important because it progressively damages weight-bearing joints and is the leading clinical pathway into knee and hip replacement.

The aging of the U.S. population will intensify this demand. Older adults experience higher rates of degenerative joint disease, osteoporosis, spinal stenosis, vertebral compression, rotator cuff pathology, and fragility fractures. Patients are also remaining physically active later in life and increasingly expect surgical treatment to restore mobility, independence, and quality of life rather than merely reduce pain.

A second major driver is the continued growth of joint replacement procedures. Total knee and hip replacement are among the most successful and economically significant elective surgeries performed in the United States. Procedure volumes are rising because of population aging, obesity, longer implant survival, improved surgical outcomes, and growing acceptance of replacement among younger and more active patients.

Revision surgery will become a larger revenue contributor as the installed base of orthopedic implants expands. Although implant survivorship has improved, the absolute number of patients requiring revision is increasing. Revision procedures generally require more complex implants, greater inventory, longer surgical time, bone-loss management, infection-control products, and specialized instruments, resulting in higher device revenue per case than uncomplicated primary replacement.

A third driver is the migration of orthopedic procedures to outpatient settings. Medicare reimbursement policies, commercial payer initiatives, hospital capacity pressure, physician ownership models, and improved perioperative protocols are supporting the movement of selected joint replacement and sports medicine procedures into ambulatory surgery centers.

The outpatient transition creates both volume opportunity and pricing pressure. Manufacturers gain access to a rapidly expanding customer base, but ambulatory facilities tend to have strict cost controls and limited tolerance for excess instrument trays or unused implant inventory. Companies that can provide efficient case support, standardized sets, compact robotic systems, and predictable bundled pricing will be favored.

A fourth driver is the rapid adoption of orthopedic surgical robotics and navigation. Robotic-assisted knee replacement has moved from a niche technology into a major competitive battleground. Platform adoption is expanding into hip, partial knee, shoulder, and spine surgery. Hospitals use these systems to recruit surgeons, differentiate orthopedic service lines, standardize procedural accuracy, and attract patients seeking technology-enabled care.

Robotics can also strengthen implant pull-through. Once a hospital adopts a proprietary system, procedure growth can increase utilization of the manufacturer’s compatible implants, disposables, software, and service contracts. This creates a long-term commercial relationship that extends beyond a single capital purchase.

A fifth driver is the persistent burden of fractures and orthopedic trauma. Millions of fractures occur annually in the United States, with age-related fragility fractures rising as the population ages. Trauma centers require immediate access to plates, screws, intramedullary nails, external fixation systems, pelvic fixation devices, and fracture-specific instrumentation.

Trauma device demand is comparatively resilient because many procedures are urgent and cannot be postponed. However, the category requires significant logistical capability. Suppliers must support broad implant inventories, rapid replenishment, emergency case coverage, and surgeon training. Companies with dependable distribution and representative support maintain an important advantage.

A sixth driver is the expansion of sports medicine and soft-tissue repair. Shoulder, knee, hip, elbow, ankle, and wrist injuries occur across professional sports, recreational activity, military service, workplace incidents, and normal aging. Arthroscopic treatment frequently uses suture anchors, fixation buttons, interference screws, graft preparation systems, cannulas, shavers, radiofrequency devices, and fluid-management equipment.

Sports medicine is attractive because it combines implantable devices, recurring disposable products, capital equipment, and biologic augmentation. It also serves a broader age range than joint reconstruction, supporting demand from adolescents, working-age adults, and active older patients.

A seventh driver is the growing economic importance of orthopedic service lines. Joint replacement, spine surgery, trauma, and sports medicine are strategically important to U.S. health systems because they generate surgery, imaging, rehabilitation, anesthesia, and follow-up revenue. Leading hospitals invest in orthopedic centers of excellence, dedicated operating rooms, navigation systems, surgical robots, and bundled-care programs to strengthen referral capture and improve patient retention.

A final driver is the density of orthopedic innovation and clinical evidence in the United States. The country has a large base of academic medical centers, orthopedic specialty hospitals, clinical registries, surgeon training programs, device engineers, and early-stage technology companies. This ecosystem supports rapid evaluation of new implants, instruments, biologics, and digital surgery platforms.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. orthopedic surgical devices market is increasingly centered on procedural consistency, personalization, inventory efficiency, minimally invasive access, and measurable patient outcomes. A technically differentiated implant remains important, but long-term competitive advantage increasingly depends on how effectively the manufacturer improves the complete surgical workflow.

Robotic-assisted joint replacement is one of the most visible innovation areas. Current platforms support preoperative planning, bone mapping, implant sizing, alignment assessment, soft-tissue balancing, and guided bone preparation. The competitive direction is moving from large robotic-arm systems toward a broader range of architectures, including handheld robotics, compact platforms, semi-autonomous systems, and potentially more autonomous execution.

The next adoption phase will depend on economics as much as accuracy. Hospitals and ambulatory surgery centers are evaluating whether robotic systems increase case volume, support surgeon recruitment, reduce variability, lower inventory requirements, or improve downstream outcomes. Flexible acquisition models and cross-procedure compatibility will become critical.

Spine surgery is undergoing a parallel transition. Robotic guidance, navigation, intraoperative imaging, AI-assisted planning, expandable interbody implants, patient-specific rods, and minimally invasive access systems are being integrated into unified surgical ecosystems. Manufacturers are attempting to extend navigation beyond pedicle-screw placement into decompression, bone preparation, implant positioning, deformity correction, and complete construct planning.

Three-dimensional printing is expanding in both standard and patient-specific orthopedic implants. Additive manufacturing enables porous structures designed to support bone ingrowth, complex geometries, customized cages, augments for bone loss, and implants adapted to unusual anatomy. The technology is especially valuable in revision arthroplasty, complex spine surgery, pelvic reconstruction, and orthopedic oncology.

Patient-specific planning is also becoming more practical. Advanced imaging and software can support customized cutting guides, implant selection, alignment targets, and reconstruction strategies. The commercial value lies in reducing intraoperative uncertainty while helping facilities control inventory and avoid opening unnecessary implant sets.

Smart instruments and connected operating rooms represent another area of development. Digital torque measurement, sensor-enabled trial components, instrument tracking, automated implant documentation, and data capture can improve traceability and workflow control. These capabilities are particularly relevant as hospitals seek stronger documentation of implant utilization, sterilization cycles, surgical efficiency, and patient outcomes.

Orthobiologics are advancing through improved bone graft substitutes, cellular products, demineralized matrices, synthetic scaffolds, growth-factor technologies, and biologic augmentation for soft-tissue repair. The clinical opportunity is substantial, but adoption depends on evidence quality, reimbursement, product handling, regulatory classification, and surgeon confidence.

In sports medicine, innovation is focused on stronger fixation, smaller implants, knotless repair, tissue preservation, biologically supported healing, and more reproducible arthroscopic workflows. Manufacturers are also combining implants with cameras, visualization systems, fluid management, radiofrequency devices, and disposable instruments to build complete procedure platforms.

Manufacturers are raising the competitive bar through clinical evidence generation. U.S. buyers increasingly expect survivorship data, registry analysis, patient-reported outcomes, complication rates, revision rates, discharge metrics, and health-economic evidence. Claims involving robotics, alignment, minimally invasive surgery, implant coatings, or biologics must increasingly be connected to clinically meaningful results rather than technical performance alone.

 

Segmentation Insights

The U.S. Orthopedic Surgical Devices Market is segmented on the basis of product category, application, technology type, end user, and region.

 

By Product Category

Joint Reconstruction Devices

Joint reconstruction represents the largest product category in the U.S. market. It includes total and partial knee systems, total hip systems, shoulder implants, elbow implants, ankle replacement devices, small-joint implants, revision systems, bone cement, and related instrumentation.

Knee replacement accounts for the largest procedural volume, while hip replacement remains a substantial premium category. Shoulder reconstruction is gaining strategic importance as anatomic and reverse shoulder arthroplasty procedures expand. Growth is also being supported by implant designs intended to improve stability, preserve bone, support outpatient surgery, and simplify revision.

Revision implants form a high-value subsegment because they require stems, cones, sleeves, augments, fixation components, and bone-loss solutions. As the installed base of joint implants expands, manufacturers with comprehensive revision portfolios and strong surgeon support will gain strategic value.

Spinal Surgery Devices

Spinal surgery devices include pedicle screws, rods, plates, interbody cages, cervical implants, thoracolumbar fixation systems, expandable cages, motion-preservation devices, vertebral augmentation products, sacroiliac joint systems, biologics, and minimally invasive access equipment.

Demand is supported by degenerative disc disease, spinal stenosis, deformity, spondylolisthesis, vertebral fracture, trauma, and chronic back pain. The market is shifting toward minimally invasive techniques, expandable implants, navigation-compatible systems, robotic guidance, and integrated procedural planning.

Spine remains commercially attractive because a single procedure may use multiple implants, biologics, instruments, imaging, and navigation. However, the category is exposed to reimbursement scrutiny, clinical-evidence requirements, surgeon preference, and hospital pressure to standardize vendors.

Trauma and Fracture Fixation Devices

Trauma devices include internal fixation plates, screws, intramedullary nails, external fixators, pins, wires, pelvic fixation systems, fracture-specific implants, and associated instrumentation. Demand is linked to falls, road accidents, workplace injuries, sports injuries, osteoporosis, and age-related fragility fractures.

The segment provides recurring demand because fractures require immediate treatment. Hospitals frequently maintain multiple fixation systems to address different anatomical sites and fracture patterns. Manufacturers compete through implant breadth, anatomical fit, instrument simplicity, supply availability, and representative support.

Fragility fractures will become increasingly important during the forecast period. Hip, wrist, ankle, proximal humerus, and distal femur fractures are common among older patients and often require specialized fixation strategies for low-quality bone.

Sports Medicine and Arthroscopy Devices

Sports medicine devices include suture anchors, interference screws, fixation buttons, graft systems, meniscal repair devices, cartilage repair products, cannulas, shavers, burrs, arthroscopic cameras, fluid-management systems, and radiofrequency instruments.

The category serves ligament, tendon, cartilage, labral, meniscal, and soft-tissue injuries. Knee and shoulder procedures account for the largest share, while hip, elbow, wrist, and ankle arthroscopy are expanding.

Sports medicine is increasingly platform-based. Manufacturers that combine implants, disposables, visualization, fluid management, biologic products, and surgeon education can secure a greater share of each procedure.

Orthobiologics and Bone-Graft Products

Orthobiologics include autograft harvesting systems, allograft products, demineralized bone matrices, synthetic bone substitutes, cellular bone matrices, growth-factor products, and soft-tissue biologics.

Spine fusion is a major application, but biologics are also used in trauma, revision arthroplasty, foot and ankle surgery, sports medicine, and complex reconstruction. Demand is influenced by fusion success, ease of handling, safety, storage requirements, clinical evidence, and reimbursement.

The category offers attractive growth potential but remains fragmented. Product differentiation can be difficult, and hospitals increasingly require stronger evidence before paying premiums for advanced biologic materials.

Orthopedic Surgical Instruments, Power Tools, and Enabling Equipment

This category includes drills, saws, reamers, burrs, surgical handpieces, implant extraction instruments, navigation equipment, robotic systems, operating-room integration, and procedure-specific disposable tools.

Power equipment produces recurring revenue through blades, batteries, attachments, and service. Robotics and navigation generate capital revenue while supporting implant pull-through and software-based recurring income. This segment is expected to grow faster than traditional manual instrumentation as digital surgery penetration rises.

 

By Application

Osteoarthritis and Degenerative Joint Disease

Osteoarthritis and degenerative joint disease represent the dominant application area. The category includes patients requiring knee, hip, shoulder, ankle, and other joint reconstruction procedures.

Demand is strongly linked to age, obesity, prior injury, activity level, and failure of conservative treatment. Joint replacement will remain the principal revenue generator, while partial replacement, outpatient arthroplasty, and personalized alignment approaches create additional growth.

Spinal Disorders

Spinal applications include degenerative disc disease, spinal stenosis, deformity, instability, vertebral fracture, trauma, and failed prior surgery. Procedures range from cervical and lumbar fusion to complex adult deformity reconstruction.

Growth will be supported by aging demographics, minimally invasive techniques, expandable implants, robotic navigation, and improved patient selection. Complex procedures remain concentrated in hospitals and academic centers, while selected cervical and lumbar cases are moving toward outpatient settings.

Trauma and Fragility Fractures

Trauma applications include upper-extremity fractures, lower-extremity fractures, pelvic injuries, hip fractures, spinal trauma, and complex polytrauma.

Demand is supported by both acute injury and age-related bone fragility. The increasing population of older adults will expand the need for fixation systems adapted to osteoporotic bone, rapid mobilization, and reduced reoperation risk.

Sports Injuries and Soft-Tissue Repair

This application includes ligament reconstruction, tendon repair, rotator cuff treatment, labral repair, meniscal repair, cartilage procedures, and instability correction.

The segment benefits from broad patient demographics and a strong outpatient footprint. Innovation is focused on minimally invasive access, stronger fixation, tissue preservation, faster recovery, and biologic augmentation.

Limb, Extremity, and Complex Reconstruction

This application covers foot and ankle surgery, hand and wrist procedures, limb deformity correction, orthopedic oncology, bone-loss reconstruction, and salvage surgery.

Although smaller than knee, hip, spine, and trauma, the segment is growing because of specialized implant development and rising surgeon interest in anatomically specific solutions. Foot and ankle has become an important strategic acquisition area because it combines trauma, reconstruction, sports medicine, and elective surgery.

 

By Technology Type

Conventional Implant and Instrument Systems

Conventional implants and manual instruments remain the largest technology category. These systems are deeply established in hospitals and ASCs and provide dependable baseline demand across joint replacement, trauma, spine, and sports medicine.

Growth will be slower than digitally enabled categories, but conventional systems will remain essential because of their broad clinical utility, lower capital requirements, and familiarity among surgeons.

Computer-Assisted Navigation

Navigation systems support implant alignment, instrument positioning, anatomical registration, and intraoperative guidance. They are widely used in spine surgery and increasingly applied in joint replacement.

Adoption is influenced by accuracy, workflow integration, imaging requirements, operating-room footprint, and compatibility with implant systems. Navigation can provide a lower-capital alternative to full robotic systems for selected facilities.

Robotic-Assisted Orthopedic Surgery

Robotic-assisted surgery is expected to be the fastest-growing technology segment. Knee replacement currently provides the largest procedure base, followed by hip and spine applications. Shoulder, partial knee, and other indications are expanding.

The segment will benefit from platform competition, smaller system footprints, more flexible purchasing models, and integration with digital planning. Future systems are expected to offer higher automation, improved workflow speed, and broader compatibility.

Three-Dimensional Printed and Patient-Specific Devices

Three-dimensional printed implants are used in spine cages, acetabular components, revision augments, trauma products, and complex reconstruction. Patient-specific solutions include customized implants, cutting guides, rods, and surgical plans.

Growth will be strongest in difficult cases where conventional implants cannot adequately address anatomy or bone loss. Manufacturing lead time, reimbursement, scalability, and regulatory requirements will determine broader adoption.

AI-Enabled, Connected, and Data-Driven Systems

AI-supported technologies are emerging across imaging, surgical planning, implant selection, navigation, operating-room workflow, and outcome prediction. Connected systems can also document implant usage, instrument movement, and procedural performance.

This segment represents a smaller direct revenue pool but will have increasing influence over platform differentiation and purchasing decisions. Manufacturers that control procedural data may gain stronger relationships with hospitals and surgeons.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks are the largest end users. They account for most complex joint revisions, spinal deformity procedures, major trauma, orthopedic oncology, and medically complicated surgery.

Large health systems often negotiate enterprise contracts, standardize implant vendors, and evaluate capital platforms through multidisciplinary committees. Their decisions influence market access, pricing, and regional adoption.

Orthopedic Specialty Hospitals and Centers of Excellence

Specialty orthopedic hospitals and dedicated musculoskeletal centers are important high-volume customers. These facilities frequently achieve strong operating-room efficiency, standardized pathways, and high procedure concentration.

They are influential adopters of robotics, navigation, rapid-recovery protocols, and advanced implant systems. Manufacturers often use these centers for training, clinical evidence, and reference-site development.

Ambulatory Surgery Centers

ASCs are expected to be the fastest-growing end-user segment. Growth is supported by outpatient joint replacement, sports medicine, hand surgery, foot and ankle procedures, and selected spine cases.

These facilities require cost-efficient implants, compact instrumentation, rapid turnover, minimal sterilization burden, and flexible capital models. Device companies must adapt hospital-oriented portfolios to the operational economics of ambulatory care.

Trauma and Emergency Care Centers

Level I and Level II trauma centers are major users of fracture fixation, external fixation, pelvic reconstruction, spinal trauma systems, and emergency surgical instruments.

Supplier reliability is critical because cases are urgent and unpredictable. Comprehensive inventory, rapid replenishment, and experienced case support are major differentiators.

Academic Medical Centers and Teaching Hospitals

Academic centers play an outsized role in innovation, clinical trials, surgeon training, registry participation, and complex reconstruction. These institutions frequently evaluate early-stage implants, robotics, navigation, biologics, and patient-specific technologies.

Although procurement is evidence-intensive, successful adoption within academic institutions can influence broader market acceptance and physician training.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Orthopedic Surgical Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population growth, age distribution, arthritis prevalence, obesity, sports participation, trauma burden, orthopedic surgeon density, hospital capacity, ASC penetration, payer mix, and investment in robotic surgery.

The South represented the largest regional market in 2025, while the West is expected to record the fastest percentage growth through 2035. The Northeast remains a premium, evidence-intensive market with a high concentration of academic institutions. The Midwest provides a stable base of joint reconstruction, trauma, spine, and orthopedic manufacturing activity.

South

The South accounted for approximately USD 11.05 billion in 2025, representing the largest regional share. The region includes Texas, Florida, Georgia, North Carolina, Virginia, Tennessee, South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, Oklahoma, Maryland, Delaware, and the District of Columbia under commonly used healthcare-market groupings.

Regional leadership is supported by rapid population growth, large older-adult populations, high rates of obesity and arthritis, expanding hospital networks, and strong migration into major metropolitan areas. The South also contains extensive trauma-care infrastructure and a growing base of physician-owned ambulatory surgery centers.

Texas is the largest orthopedic surgical devices market in the region. Houston, Dallas–Fort Worth, Austin, and San Antonio contain large academic systems, trauma centers, orthopedic groups, and specialty hospitals. Demand spans joint replacement, spine surgery, trauma fixation, sports medicine, and enabling technology. The state’s geographic size and population growth support continued expansion of satellite hospitals and outpatient surgical facilities.

Florida is a major joint reconstruction and fragility-fracture market because of its large senior population. Knee replacement, hip replacement, shoulder arthroplasty, fracture fixation, and spine procedures generate substantial implant demand. Florida also has a mature ASC market, making it strategically important for outpatient orthopedic systems, compact robotics, and simplified instrument sets.

North Carolina has strong academic orthopedic programs, rapidly growing metropolitan areas, and an expanding life-sciences economy. Charlotte, Raleigh-Durham, Winston-Salem, and surrounding markets support advanced joint, spine, trauma, and sports medicine procedures. The state is attractive for both premium hospital technology and outpatient expansion.

Georgia benefits from Atlanta’s large referral network, population growth, and strong orthopedic sports medicine demand. Tennessee has influential orthopedic institutions and a substantial concentration of healthcare companies, while Virginia combines affluent metropolitan markets with major integrated delivery networks and military-associated care.

Maryland and the District of Columbia support complex surgery, research, teaching, and federal healthcare activity. South Carolina is growing through migration and expansion of orthopedic capacity around Charleston, Columbia, and Greenville.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, and Oklahoma present a combination of high musculoskeletal disease burden and access limitations. Major regional centers perform complex orthopedic surgery, but rural communities may face shortages of orthopedic specialists and longer travel distances. This creates demand for efficient referral networks, durable trauma inventories, telehealth-supported follow-up, and surgical solutions suited to community hospitals.

The South is projected to remain the largest market through 2035 and could approach USD 23.20 billion, supported by an estimated regional CAGR of approximately 7.7%. Growth will be driven by joint replacement, ASC expansion, trauma, robotic surgery, and increased investment in orthopedic service lines.

West

The West accounted for approximately USD 7.10 billion in 2025 and is expected to record the fastest regional growth through 2035. The region includes California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest state market in the West and one of the largest orthopedic markets nationally. Its size is supported by major academic medical centers, large integrated health systems, sports medicine demand, advanced spine programs, and a strong medical-technology innovation ecosystem.

California providers are influential early adopters of robotic surgery, digital planning, 3D-printed implants, outpatient joint replacement, and data-driven care pathways. The state also has significant variation between premium metropolitan systems and rural or safety-net providers, requiring flexible pricing and service models.

Arizona and Nevada are among the fastest-growing orthopedic markets because of migration, retirement populations, and hospital expansion. Arizona has strong demand for joint reconstruction, spinal surgery, fragility-fracture treatment, and outpatient care. Nevada is adding surgical capacity in Las Vegas and surrounding population centers.

Colorado and Utah combine active populations with sophisticated provider systems. Sports injuries, spine procedures, trauma, and joint replacement are important demand categories. Both states are receptive to minimally invasive and technology-enabled surgery.

Washington and Oregon have large integrated health systems and strong adoption of evidence-based procurement, outpatient pathways, and digital health. Their purchasing committees typically place high emphasis on clinical data, supply reliability, sustainability, and enterprise economics.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets but require specialized distribution strategies. Geographic distance, rural populations, and limited specialist access can increase the value of dependable inventories, regional training, and compact surgical systems.

The West could reach approximately USD 15.65 billion by 2035, reflecting an estimated CAGR of around 8.25%. Growth will be driven by population migration, technology adoption, outpatient surgery, sports medicine, spine innovation, and the concentration of digital and robotic capabilities.

Northeast

The Northeast represented approximately USD 6.55 billion in 2025. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine.

New York is the largest state market in the Northeast. New York City contains major academic hospitals, orthopedic specialty institutions, complex spine programs, trauma centers, and high-volume joint replacement practices. Upstate markets add substantial community hospital and regional referral demand.

Pennsylvania is another large orthopedic market, supported by Philadelphia, Pittsburgh, and statewide health-system networks. Joint replacement, spine surgery, sports medicine, trauma, and orthopedic research all contribute to device demand.

New Jersey benefits from population density, affluent suburban markets, outpatient surgery, and proximity to both New York and Philadelphia. The state is attractive for ambulatory joint replacement, sports medicine, and physician-owned facilities.

Massachusetts has a smaller population but an outsized strategic role because of its academic institutions, clinical research, medical-device innovation, and complex orthopedic care. Provider systems in the state are influential in evaluating new implants, robotics, biologics, and surgical techniques.

Connecticut, Rhode Island, New Hampshire, Vermont, and Maine provide smaller but clinically sophisticated markets. New England systems often use rigorous value analysis and may standardize purchasing across regional networks.

The Northeast is characterized by high procedure complexity, strong specialist density, and extensive clinical evidence requirements. Growth is moderated by slower population expansion and mature hospital infrastructure, but the region remains attractive for premium implants, revision surgery, robotics, spine technologies, and academic collaboration.

The Northeast could reach approximately USD 12.60 billion by 2035, reflecting an estimated CAGR of approximately 6.75%.

Midwest

The Midwest accounted for approximately USD 5.95 billion in 2025. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest market in the region, with Chicago supporting a dense mix of academic institutions, community hospitals, orthopedic practices, trauma centers, and ASCs. The state generates demand across all major orthopedic device categories.

Ohio has strong orthopedic and spine programs in Cleveland, Columbus, Cincinnati, and surrounding regional systems. The state’s large hospital networks provide attractive opportunities for enterprise contracting and vendor standardization.

Michigan supports substantial joint reconstruction, trauma, and spine demand. Minnesota is strategically important because of its medical-device heritage, orthopedic expertise, and concentration of technology development. The state also contains leading health systems that influence procedural innovation.

Indiana has a unique role in the orthopedic industry because of the concentration of major implant manufacturers and suppliers around Warsaw and surrounding areas. The state functions as both an end market and a manufacturing center for joint reconstruction, trauma, instruments, and enabling technologies.

Wisconsin, Missouri, Iowa, and Kansas provide stable procedure volumes and strong regional referral networks. Nebraska, North Dakota, and South Dakota are smaller markets but are important for trauma systems, community hospitals, and rural access.

The Midwest is expected to grow more steadily than the South or West. Buyers often emphasize service reliability, clinical education, cost discipline, and long-term supplier relationships. The region could reach approximately USD 10.85 billion by 2035, reflecting an estimated CAGR of approximately 6.2%.

 

Key Market Players

The U.S. Orthopedic Surgical Devices Competitive Landscape is moderately consolidated in major joint reconstruction and spine categories, while remaining fragmented across biologics, extremities, sports medicine, trauma, and specialized surgical technologies.

Competition is increasingly ecosystem-based. Leading companies combine implants with instruments, robotics, navigation, imaging, data systems, disposables, clinical training, and enterprise contracting. The largest manufacturers can use capital platforms to support recurring implant utilization and develop long-term hospital relationships.

Some of the key participants in the U.S. Orthopedic Surgical Devices industry include Stryker Corporation, Zimmer Biomet Holdings, DePuy Synthes, Medtronic, Smith+Nephew, Globus Medical, Arthrex, Enovis Corporation, Integra LifeSciences, CONMED Corporation, Orthofix Medical, Alphatec Holdings, B. Braun Aesculap, MicroPort Orthopedics, Exactech, Acumed, restor3d, SI-BONE, SeaSpine technologies within the Orthofix portfolio, Aspen Surgical, Treace Medical Concepts, Anika Therapeutics, Bioventus, and Colson Medical.

Stryker, Zimmer Biomet, and DePuy Synthes hold strong positions in joint reconstruction, trauma, and digital orthopedic surgery. Their scale supports broad implant portfolios, surgeon education, national contracting, and significant investment in robotic platforms.

Medtronic and Globus Medical are major competitors in spine surgery, navigation, robotic guidance, implants, biologics, and enabling technology. Their strategic direction reflects the integration of procedural planning, imaging, robotics, instruments, and implant systems.

Smith+Nephew and Arthrex are particularly influential in sports medicine, arthroscopy, soft-tissue repair, and shoulder procedures. Both compete through procedure-specific innovation, clinical education, and comprehensive surgical workflows.

Enovis, Acumed, Exactech, MicroPort, SI-BONE, Treace Medical Concepts, and restor3d compete through differentiated positions in extremities, joint reconstruction, sacroiliac treatment, bunion correction, and patient-specific or additively manufactured implants.

Market share during the forecast period will be influenced by implant survivorship, robotic-platform adoption, surgeon loyalty, ASC strategy, regulatory approvals, product recalls, supply-chain reliability, clinical evidence, contracting flexibility, and case-support quality.

 

Recent Developments

Recent developments in the U.S. Orthopedic Surgical Devices Market demonstrate a decisive shift toward robotics, portfolio consolidation, foot and ankle expansion, advanced spine navigation, and digitally integrated surgery.

Zimmer Biomet completed its acquisition of Paragon 28 in 2025, expanding its position in foot and ankle implants, trauma, and extremity reconstruction. The transaction reflects growing strategic interest in specialized anatomical markets that offer higher growth than mature primary hip and knee categories.

Zimmer Biomet also moved to expand its robotic portfolio through an agreement to acquire Monogram Technologies. Monogram’s development pipeline includes semi-autonomous and potentially autonomous orthopedic robotics. This highlights the direction of competition toward broader robotic architectures rather than a single standardized system.

Stryker continued to expand the Mako platform across knee, hip, and shoulder applications and introduced an additional robotic power-system architecture for total knee replacement. The expansion illustrates how leading companies are attempting to address different surgeon preferences, facility footprints, and capital budgets.

DePuy Synthes expanded the clinical application of its VELYS robotic-assisted platform into unicompartmental knee arthroplasty. Partial knee replacement is strategically relevant because it preserves more bone and may fit efficiently within outpatient surgical pathways when patient selection is appropriate.

Medtronic advanced its spine surgery ecosystem through new navigation, robotic-guidance, imaging, software, AI, and deformity technologies. The company’s development of integrated planning and execution platforms reinforces the movement toward complete digital spine workflows.

Globus Medical continued to integrate its spine, trauma, implant, navigation, and robotic capabilities following its combination with NuVasive. The company’s broad musculoskeletal portfolio creates stronger competition for hospitals seeking fewer vendors and integrated technology platforms.

Johnson & Johnson announced its intention to separate its orthopedics business into a standalone company operating as DePuy Synthes. The proposed separation could create one of the world’s largest dedicated orthopedic companies and may provide greater strategic focus for joint reconstruction, trauma, spine, sports medicine, and digital surgery.

Across the market, manufacturers are increasing investment in shoulder robotics, compact systems for ASCs, 3D-printed implants, augmented-reality planning, minimally invasive spine surgery, and digital data platforms. Consolidation is expected to continue as larger companies seek specialized technologies in extremities, biologics, navigation, and outpatient surgery.

 

Conclusion

The U.S. Orthopedic Surgical Devices Market Size & Share is positioned for sustained expansion from approximately USD 30.65 billion in 2025 to USD 62.30 billion by 2035, supported by a CAGR of 7.35% during the forecast period 2026–2035.

The market’s long-term strength is grounded in the scale of arthritis and osteoarthritis, population aging, rising joint replacement volumes, recurring trauma demand, growth in sports medicine, expansion of spine surgery, and increasing patient expectations for mobility and functional recovery.

Joint reconstruction will remain the largest product category, while robotic-assisted surgery, navigation, patient-specific implants, outpatient technologies, advanced spine systems, and biologics will generate faster value growth. Revision arthroplasty and complex reconstruction will also become more important as the installed base of orthopedic implants expands.

The shift toward ambulatory surgery will reshape product design and commercial strategy. Manufacturers will need to provide smaller instrument footprints, predictable procedure economics, efficient logistics, and flexible capital arrangements. Systems originally developed for large hospitals may require redesign or alternative pricing to succeed in physician-owned and independent ASCs.

Regional growth will be led by the South because of population scale, migration, aging demographics, and expanding surgical capacity. The West will record the fastest percentage growth because of technology adoption and population expansion. The Northeast will remain a premium market for evidence-intensive and complex care, while the Midwest will provide stable demand and remain central to orthopedic manufacturing and clinical expertise.

For clients evaluating this market, the critical issue is no longer whether orthopedic surgical demand will expand. The more important questions are which procedures will migrate to outpatient settings, which robotic architectures will achieve sustainable utilization, how hospital systems will consolidate implant vendors, and which technologies can demonstrate measurable clinical and economic value.

Companies that combine durable implants, efficient instrumentation, digital planning, robotic execution, clinical evidence, reimbursement support, and dependable case coverage will be best positioned to define the next decade of the U.S. orthopedic surgical devices industry.

 

TABLE OF CONTENT

1. U.S. Orthopedic Surgical Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Orthopedic Implant and Surgical Device Manufacturers
1.6.2. Biomaterial, Component, and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Orthopedic Specialty Hospitals and Musculoskeletal Centers
1.6.5. Ambulatory Surgery Centers and Physician-Owned Facilities
1.6.6. Group Purchasing Organizations and Medical Device Distributors
1.6.7. Orthopedic Surgeons, Clinical Decision-Makers, Payers, and Regulators

What this section provides: This section defines the market boundary, report scope, research methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. orthopedic surgical devices market is measured, segmented, and validated.

2. U.S. Orthopedic Surgical Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.7.1. Robotic-Assisted Joint Reconstruction
2.7.2. Outpatient Hip and Knee Arthroplasty
2.7.3. Minimally Invasive Spine Surgery
2.7.4. Extremity and Foot and Ankle Devices
2.7.5. Three-Dimensional Printed and Patient-Specific Implants
2.7.6. Orthobiologics and Tissue-Healing Technologies

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast direction, competitive intensity, procedure-driven demand, and the most attractive orthopedic surgical device opportunities through 2035.

3. U.S. Orthopedic Surgical Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Prevalence of Osteoarthritis and Degenerative Joint Disease
3.1.2. Aging U.S. Population and Growth in Fragility Fractures
3.1.3. Increasing Hip, Knee, Shoulder, and Extremity Reconstruction Procedures
3.1.4. Expansion of Minimally Invasive Spine Surgery
3.1.5. Growth in Sports Injuries and Arthroscopic Procedures
3.1.6. Migration of Orthopedic Procedures to Ambulatory Surgery Centers
3.1.7. Adoption of Robotic-Assisted and Navigation-Guided Surgery
3.1.8. Rising Demand for Revision Arthroplasty and Complex Reconstruction
3.2. Restraints and Their Impact Analysis
3.2.1. High Cost of Orthopedic Implants and Surgical Enabling Technologies
3.2.2. Hospital Pricing Pressure and Implant Vendor Consolidation
3.2.3. Reimbursement Constraints and Bundled-Payment Exposure
3.2.4. Product Recall, Implant Failure, and Litigation Risk
3.2.5. Surgeon Learning-Curve and Training Requirements
3.2.6. Sterilization, Inventory, and Instrument-Set Management Burden
3.3. Opportunities and Their Impact Analysis
3.3.1. Robotic-Assisted Joint Replacement Expansion
3.3.2. Compact Orthopedic Robotics for Ambulatory Surgery Centers
3.3.3. Three-Dimensional Printed and Patient-Specific Implants
3.3.4. Smart Implants and Connected Surgical Workflows
3.3.5. Orthobiologics and Bone-Regeneration Technologies
3.3.6. Foot, Ankle, Shoulder, and Small-Joint Reconstruction
3.3.7. Outpatient Total Joint Replacement
3.3.8. Revision and Complex Orthopedic Reconstruction
3.4. Challenges and Their Impact Analysis
3.4.1. Shortage of Orthopedic Surgeons and Specialized Operating-Room Staff
3.4.2. Uneven Access to Advanced Orthopedic Care
3.4.3. Clinical Evidence Requirements for Premium Technologies
3.4.4. Supply-Chain Dependence on Specialized Metals, Polymers, and Components
3.4.5. Hospital Resistance to Additional Capital Platforms
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.6.1. Operating-Room Time and Surgical Throughput
3.6.2. Implant Inventory and Sterilization Economics
3.6.3. Length of Stay and Same-Day Discharge
3.6.4. Revision Risk and Lifetime Episode Cost
3.6.5. Postoperative Rehabilitation and Readmission Economics
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Robotic-System Procurement Criteria
3.7.2. Navigation and Imaging Platform Evaluation
3.7.3. Implant Pull-Through and Capital Placement Models
3.7.4. Surgeon Preference Versus Enterprise Standardization
3.7.5. ASC-Oriented Capital Acquisition Models

What this section provides: This section explains the demographic, clinical, reimbursement, technological, and operating-room forces shaping orthopedic device demand, helping clients evaluate market upside, purchasing behavior, and execution risk.

4. U.S. Orthopedic Surgical Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.3.1. Primary Joint Reconstruction Implant Pricing
4.3.2. Revision Implant Pricing
4.3.3. Spine Implant and Biologic Pricing
4.3.4. Trauma Fixation Device Pricing
4.3.5. Sports Medicine Disposable and Implant Pricing
4.3.6. Robotic and Navigation Platform Pricing
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Materials and Biomaterials
4.4.2. Precision Manufacturing and Additive Manufacturing
4.4.3. Implant and Instrument Assembly
4.4.4. Sterilization and Packaging
4.4.5. Distribution and Case Support
4.4.6. Hospital and ASC Utilization
4.5. Impact of Digitalization and Connected Orthopedic Surgery
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. 510(k) Premarket Notification Pathway
4.7.2. Premarket Approval Pathway
4.7.3. De Novo Classification Pathway
4.7.4. Humanitarian Device Exemptions
4.7.5. Quality System and Post-Market Surveillance Requirements
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Inpatient Prospective Payment System
4.8.2. Hospital Outpatient Prospective Payment System
4.8.3. Ambulatory Surgical Center Payment System
4.8.4. Medicare Bundled-Payment and Value-Based Care Models
4.8.5. Commercial Payer Coverage and Prior Authorization
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Musculoskeletal Health Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital Value Analysis Committee Decision Framework
4.12.1. Clinical Outcomes and Implant Survivorship
4.12.2. Acquisition Cost and Total Procedure Economics
4.12.3. Surgeon Preference and Training Requirements
4.12.4. Instrument-Tray and Sterilization Burden
4.12.5. Supply Reliability and Emergency Case Coverage
4.12.6. Robotic Utilization and Return on Investment

What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply-chain exposure, digital adoption, implant economics, and hospital procurement requirements.

5. U.S. Orthopedic Surgical Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Joint Reconstruction Devices
5.1.2.1. Knee Reconstruction Devices
5.1.2.2. Hip Reconstruction Devices
5.1.2.3. Shoulder Reconstruction Devices
5.1.2.4. Elbow and Small-Joint Reconstruction Devices
5.1.2.5. Ankle Replacement Devices
5.1.2.6. Primary Joint Replacement Systems
5.1.2.7. Revision Joint Replacement Systems
5.1.2.8. Bone Cement and Fixation Accessories
5.1.3. Spinal Surgery Devices
5.1.3.1. Thoracolumbar Fixation Systems
5.1.3.2. Cervical Fixation Systems
5.1.3.3. Interbody Fusion Devices
5.1.3.4. Expandable Interbody Cages
5.1.3.5. Motion-Preservation Devices
5.1.3.6. Vertebral Compression Fracture Devices
5.1.3.7. Sacroiliac Joint Fusion Devices
5.1.3.8. Minimally Invasive Spine Surgery Systems
5.1.4. Trauma and Fracture Fixation Devices
5.1.4.1. Plates and Screws
5.1.4.2. Intramedullary Nails
5.1.4.3. External Fixation Systems
5.1.4.4. Pins, Wires, and Staples
5.1.4.5. Pelvic and Acetabular Fixation Systems
5.1.4.6. Upper-Extremity Trauma Devices
5.1.4.7. Lower-Extremity Trauma Devices
5.1.4.8. Fragility-Fracture Fixation Devices
5.1.5. Sports Medicine and Arthroscopy Devices
5.1.5.1. Suture Anchors
5.1.5.2. Interference Screws
5.1.5.3. Fixation Buttons and Soft-Tissue Fixation Devices
5.1.5.4. Meniscal Repair Devices
5.1.5.5. Ligament Reconstruction Systems
5.1.5.6. Cartilage Repair Devices
5.1.5.7. Arthroscopic Visualization Systems
5.1.5.8. Shavers, Burrs, and Radiofrequency Devices
5.1.5.9. Fluid-Management Systems
5.1.6. Orthobiologics and Bone-Graft Products
5.1.6.1. Bone-Graft Substitutes
5.1.6.2. Demineralized Bone Matrices
5.1.6.3. Cellular Bone Matrices
5.1.6.4. Synthetic Bone-Graft Materials
5.1.6.5. Growth-Factor Products
5.1.6.6. Allograft Products
5.1.6.7. Autograft Harvesting Systems
5.1.6.8. Soft-Tissue Biologic Products
5.1.7. Orthopedic Surgical Instruments, Power Tools, and Enabling Equipment
5.1.7.1. Surgical Drills and Reamers
5.1.7.2. Surgical Saws and Blades
5.1.7.3. Burrs and Handpieces
5.1.7.4. Manual Orthopedic Instruments
5.1.7.5. Implant Extraction Systems
5.1.7.6. Robotic-Assisted Surgical Systems
5.1.7.7. Computer Navigation Systems
5.1.7.8. Intraoperative Imaging and Operating-Room Integration Systems

What this section provides: This section identifies which orthopedic implant, fixation, biologic, instrument, and enabling-technology categories will generate the largest revenue contribution and strongest growth through 2035.

6. U.S. Orthopedic Surgical Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Osteoarthritis and Degenerative Joint Disease
6.1.2.1. Knee Osteoarthritis
6.1.2.2. Hip Osteoarthritis
6.1.2.3. Shoulder Arthritis
6.1.2.4. Ankle and Small-Joint Arthritis
6.1.2.5. Primary Joint Replacement
6.1.2.6. Revision Joint Replacement
6.1.3. Spinal Disorders
6.1.3.1. Degenerative Disc Disease
6.1.3.2. Spinal Stenosis
6.1.3.3. Spondylolisthesis
6.1.3.4. Spinal Deformity
6.1.3.5. Vertebral Compression Fractures
6.1.3.6. Cervical Spine Disorders
6.1.3.7. Failed Back Surgery and Revision Procedures
6.1.4. Trauma and Fragility Fractures
6.1.4.1. Hip and Femur Fractures
6.1.4.2. Tibia and Ankle Fractures
6.1.4.3. Pelvic and Acetabular Fractures
6.1.4.4. Shoulder and Proximal Humerus Fractures
6.1.4.5. Hand and Wrist Fractures
6.1.4.6. Polytrauma and Complex Reconstruction
6.1.5. Sports Injuries and Soft-Tissue Repair
6.1.5.1. Anterior Cruciate Ligament Reconstruction
6.1.5.2. Rotator Cuff Repair
6.1.5.3. Meniscal Repair
6.1.5.4. Labral Repair
6.1.5.5. Tendon Repair
6.1.5.6. Cartilage Restoration
6.1.5.7. Joint Instability Treatment
6.1.6. Extremity and Complex Reconstruction
6.1.6.1. Foot and Ankle Reconstruction
6.1.6.2. Hand and Wrist Surgery
6.1.6.3. Limb Deformity Correction
6.1.6.4. Orthopedic Oncology Reconstruction
6.1.6.5. Limb Salvage Procedures
6.1.6.6. Complex Bone-Loss Reconstruction

What this section provides: This section helps clients understand demand by orthopedic indication and surgical use case, enabling prioritization of applications with strong procedure growth, premium device utilization, and unmet clinical needs.

7. U.S. Orthopedic Surgical Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Large Integrated Delivery Networks
7.1.2.2. Community Hospitals
7.1.2.3. Regional Referral Hospitals
7.1.2.4. Rural and Critical Access Hospitals
7.1.3. Orthopedic Specialty Hospitals and Centers of Excellence
7.1.3.1. Joint Replacement Centers
7.1.3.2. Spine Surgery Centers
7.1.3.3. Sports Medicine Centers
7.1.3.4. Musculoskeletal Institutes
7.1.4. Ambulatory Surgery Centers
7.1.4.1. Hospital-Owned Ambulatory Surgery Centers
7.1.4.2. Physician-Owned Ambulatory Surgery Centers
7.1.4.3. Joint-Venture Ambulatory Surgery Centers
7.1.4.4. Independent Multispecialty Surgery Centers
7.1.5. Trauma and Emergency Care Centers
7.1.5.1. Level I Trauma Centers
7.1.5.2. Level II Trauma Centers
7.1.5.3. Regional Emergency and Fracture Care Facilities
7.1.6. Academic Medical Centers and Teaching Hospitals
7.1.6.1. Clinical Research Institutions
7.1.6.2. Orthopedic Residency and Fellowship Centers
7.1.6.3. Complex Reconstruction and Referral Centers

What this section provides: This section explains which care settings and customer groups are expected to drive implant utilization, capital-system purchasing, outpatient procedure migration, and adoption of advanced orthopedic technologies.

8. U.S. Orthopedic Surgical Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Conventional Implant and Instrument Systems
8.1.2.1. Standard Metallic Implants
8.1.2.2. Polymer and Ceramic Implant Components
8.1.2.3. Manual Surgical Instruments
8.1.2.4. Conventional Power Tools
8.1.3. Computer-Assisted Navigation Systems
8.1.3.1. Image-Based Navigation
8.1.3.2. Imageless Navigation
8.1.3.3. Optical Tracking Systems
8.1.3.4. Electromagnetic Tracking Systems
8.1.4. Robotic-Assisted Orthopedic Surgery
8.1.4.1. Robotic Knee Replacement
8.1.4.2. Robotic Hip Replacement
8.1.4.3. Robotic Shoulder Replacement
8.1.4.4. Robotic Spine Surgery
8.1.4.5. Handheld Robotic Systems
8.1.4.6. Semi-Autonomous and Autonomous Robotic Systems
8.1.5. Three-Dimensional Printed and Patient-Specific Devices
8.1.5.1. Additively Manufactured Standard Implants
8.1.5.2. Patient-Specific Joint Implants
8.1.5.3. Patient-Specific Spine Implants
8.1.5.4. Customized Trauma and Reconstruction Devices
8.1.5.5. Patient-Specific Cutting Guides and Instruments
8.1.6. AI-Enabled, Connected, and Data-Driven Systems
8.1.6.1. AI-Assisted Preoperative Planning
8.1.6.2. Digital Templating and Implant Selection
8.1.6.3. Connected Operating-Room Platforms
8.1.6.4. Smart Instruments and Sensor-Enabled Devices
8.1.6.5. Surgical Data Analytics and Outcome Prediction
8.1.6.6. Remote Postoperative Monitoring Platforms

What this section provides: This section evaluates conventional and emerging technology platforms shaping orthopedic surgery, including navigation, robotics, additive manufacturing, artificial intelligence, smart instruments, and connected surgical workflows.

9. U.S. Orthopedic Surgical Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Facility-Level Implant Contracts
9.1.2.2. Capital Equipment Purchases
9.1.2.3. Long-Term Service and Maintenance Agreements
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. System-Wide Vendor Standardization
9.1.3.2. Multi-Hospital Implant Agreements
9.1.3.3. Capital Placement and Implant Pull-Through Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Agreements
9.1.4.2. Regional GPO Agreements
9.1.4.3. Aggregated ASC Purchasing Programs
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. National Medical Device Distributors
9.1.5.2. Regional Orthopedic Distributors
9.1.5.3. Independent Sales Agencies
9.1.5.4. Trauma and Emergency Inventory Suppliers
9.1.6. Ambulatory and Physician-Owned Facility Procurement
9.1.6.1. Direct ASC Contracting
9.1.6.2. Physician Preference Agreements
9.1.6.3. Bundled Case-Pricing Models
9.1.6.4. Leasing and Usage-Based Capital Models

What this section provides: This section explains how orthopedic surgical devices are purchased in the United States, including hospital contracting, IDN standardization, GPO influence, distributor relationships, implant pull-through, and ASC procurement behavior.

10. U.S. Orthopedic Surgical Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Orthopedic Procedure Volume and Surgical Infrastructure Analysis
10.1.4. Regional Musculoskeletal Disease and Trauma Burden Analysis
10.1.5. Regional Reimbursement and Procurement Dynamics
10.1.6. Regional ASC Penetration and Outpatient Procedure Migration
10.1.7. Regional Robotic Surgery and Navigation Adoption

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Orthopedic Surgical Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Orthopedic Surgical Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Orthopedic Surgical Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Orthopedic Surgical Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. markets, orthopedic procedure hubs, ASC expansion areas, robotic-surgery adoption hotspots, trauma-care demand, and state-level commercial opportunities.

11. U.S. Orthopedic Surgical Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Market Share by Product Category
11.1.2. Market Share by Major Orthopedic Manufacturer
11.1.3. Market Concentration and Competitive Intensity
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Stryker Corporation
11.3.2. Zimmer Biomet Holdings, Inc.
11.3.3. DePuy Synthes
11.3.4. Medtronic
11.3.5. Smith+Nephew
11.3.6. Globus Medical, Inc.
11.3.7. Arthrex, Inc.
11.3.8. Enovis Corporation
11.3.9. Integra LifeSciences Holdings Corporation
11.3.10. CONMED Corporation
11.3.11. Orthofix Medical Inc.
11.3.12. Alphatec Holdings, Inc.
11.3.13. B. Braun Aesculap
11.3.14. MicroPort Orthopedics Inc.
11.3.15. Exactech, Inc.
11.3.16. Acumed LLC
11.3.17. restor3d, Inc.
11.3.18. SI-BONE, Inc.
11.3.19. Treace Medical Concepts, Inc.
11.3.20. Anika Therapeutics, Inc.
11.3.21. Bioventus Inc.
11.3.22. Colson Medical, LLC
11.3.23. Aspen Surgical Products, Inc.
11.3.24. Medacta International
11.3.25. OSSIO Ltd.
11.4. Competitive Strategy Assessment
11.4.1. Portfolio Breadth and Procedure Coverage
11.4.2. Robotic and Navigation Platform Strategy
11.4.3. ASC Market Strategy
11.4.4. Surgeon Education and Clinical Support
11.4.5. Mergers, Acquisitions, and Portfolio Expansion
11.4.6. Pricing and Contracting Strategy
11.4.7. Regulatory and Product Recall Exposure

Note: Each company profile will include company overview, orthopedic surgical device portfolio, U.S. market strategy, financial positioning, innovation and clinical pipeline, regulatory updates, robotic or navigation capabilities, partnerships, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, robotic-platform strategy, outpatient-market readiness, innovation direction, and strategic intelligence on major orthopedic device companies.

12. U.S. Orthopedic Surgical Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Robotic-Assisted Joint Reconstruction
12.2.2. Robotic and Navigation-Guided Spine Surgery
12.2.3. Three-Dimensional Printed and Patient-Specific Implants
12.2.4. AI-Assisted Surgical Planning and Data Analytics
12.2.5. Smart Implants and Sensor-Enabled Instruments
12.2.6. Orthobiologics and Tissue-Regeneration Technologies
12.2.7. Augmented-Reality and Mixed-Reality Surgical Guidance
12.2.8. Compact Surgical Platforms for Ambulatory Surgery Centers
12.3. Emerging Business Trends
12.3.1. Implant Vendor Consolidation
12.3.2. Capital Placement and Implant Pull-Through Models
12.3.3. Migration to Same-Day Joint Replacement
12.3.4. Procedure Bundling and Case-Based Pricing
12.3.5. Expansion into Foot, Ankle, Shoulder, and Extremities
12.3.6. Digitally Connected Orthopedic Care Pathways
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.5.1. Market Growth Potential
12.5.2. Competitive Intensity
12.5.3. Reimbursement Attractiveness
12.5.4. Regulatory Complexity
12.5.5. Capital Requirements
12.5.6. Clinical Adoption Potential

What this section provides: This section prepares clients for future technology shifts, outpatient migration, competitive restructuring, investment opportunities, and potential orthopedic surgical device adoption scenarios through 2035.

13. U.S. Orthopedic Surgical Devices Market: Strategic Recommendations

13.1. Recommendations for Orthopedic Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Orthopedic Specialty Hospitals
13.4. Recommendations for Ambulatory Surgery Centers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.8.1. Surgeon Engagement Strategy
13.8.2. Hospital and IDN Contracting Strategy
13.8.3. ASC Market Entry Strategy
13.8.4. Regional Distributor Strategy
13.8.5. Clinical Evidence and Reimbursement Strategy
13.9. Product Positioning and Portfolio Expansion Guidance
13.9.1. Joint Reconstruction Portfolio Expansion
13.9.2. Spine and Navigation Portfolio Expansion
13.9.3. Trauma and Extremity Portfolio Expansion
13.9.4. Sports Medicine Platform Development
13.9.5. Robotics and Digital Surgery Investment
13.9.6. Orthobiologics and Regenerative Technology Investment

What this section provides: This section converts market intelligence into actionable recommendations for growth planning, portfolio development, hospital contracting, ASC expansion, investment decisions, channel strategy, and competitive differentiation.

14. U.S. Orthopedic Surgical Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Estimation and Assumption Disclaimer
14.7. Company and Product Information Disclaimer
14.8. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section clarifies the report’s scope limitations, legal boundaries, data-use terms, forecasting assumptions, company-information treatment, and regulatory and reimbursement limitations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Orthopedic Surgical Devices Market: Market Definition and Scope
TABLE 3: U.S. Orthopedic Surgical Devices Market: Research Methodology Framework
TABLE 4: U.S. Orthopedic Surgical Devices Market: Key Assumptions
TABLE 5: U.S. Orthopedic Surgical Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Orthopedic Surgical Devices Market: Stakeholder Analysis
TABLE 7: U.S. Orthopedic Surgical Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Orthopedic Surgical Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Orthopedic Surgical Devices Market: Market Attractiveness Index
TABLE 10: U.S. Orthopedic Surgical Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Orthopedic Surgical Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Orthopedic Surgical Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Orthopedic Surgical Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Orthopedic Surgical Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Orthopedic Surgical Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Orthopedic Surgical Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Orthopedic Surgical Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Orthopedic Surgical Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Orthopedic Surgical Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Orthopedic Surgical Devices Market: PESTEL Analysis
TABLE 21: U.S. Orthopedic Surgical Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Orthopedic Surgical Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Orthopedic Surgical Devices Market: Value Chain Analysis
TABLE 24: U.S. Orthopedic Surgical Devices Market: Supply Chain Analysis
TABLE 25: U.S. Orthopedic Surgical Devices Market: Digitalization and Connected Orthopedic Surgery Impact
TABLE 26: U.S. Orthopedic Surgical Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Orthopedic Surgical Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Orthopedic Surgical Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Orthopedic Surgical Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Orthopedic Surgical Devices Market: Government Initiatives and Musculoskeletal Health Programs
TABLE 31: U.S. Orthopedic Surgical Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Orthopedic Surgical Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 33: U.S. Orthopedic Surgical Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Orthopedic Surgical Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Orthopedic Surgical Devices Market: Joint Reconstruction Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Orthopedic Surgical Devices Market: Spinal Surgery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Orthopedic Surgical Devices Market: Trauma and Fracture Fixation Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Orthopedic Surgical Devices Market: Sports Medicine and Arthroscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Orthopedic Surgical Devices Market: Orthobiologics and Bone-Graft Products Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Orthopedic Surgical Devices Market: Orthopedic Surgical Instruments, Power Tools, and Enabling Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Orthopedic Surgical Devices Market: Application Snapshot, 2025
TABLE 44: Segment Dashboard; Definition and Scope, by Application
TABLE 45: U.S. Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 46: U.S. Orthopedic Surgical Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 47: U.S. Orthopedic Surgical Devices Market: Osteoarthritis and Degenerative Joint Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Orthopedic Surgical Devices Market: Spinal Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Orthopedic Surgical Devices Market: Trauma and Fragility Fractures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Orthopedic Surgical Devices Market: Sports Injuries and Soft-Tissue Repair Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Orthopedic Surgical Devices Market: Extremity and Complex Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Orthopedic Surgical Devices Market: End User Snapshot, 2025
TABLE 53: Segment Dashboard; Definition and Scope, by End User
TABLE 54: U.S. Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 55: U.S. Orthopedic Surgical Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 56: U.S. Orthopedic Surgical Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Orthopedic Surgical Devices Market: Orthopedic Specialty Hospitals and Centers of Excellence Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Orthopedic Surgical Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Orthopedic Surgical Devices Market: Trauma and Emergency Care Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Orthopedic Surgical Devices Market: Academic Medical Centers and Teaching Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Orthopedic Surgical Devices Market: Technology Type Snapshot, 2025
TABLE 62: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 63: U.S. Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 64: U.S. Orthopedic Surgical Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 65: U.S. Orthopedic Surgical Devices Market: Conventional Implant and Instrument Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Orthopedic Surgical Devices Market: Computer-Assisted Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Orthopedic Surgical Devices Market: Robotic-Assisted Orthopedic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Orthopedic Surgical Devices Market: Three-Dimensional Printed and Patient-Specific Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Orthopedic Surgical Devices Market: AI-Enabled, Connected, and Data-Driven Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Orthopedic Surgical Devices Market: Procurement Channel Snapshot, 2025
TABLE 71: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 72: U.S. Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 73: U.S. Orthopedic Surgical Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 74: U.S. Orthopedic Surgical Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Orthopedic Surgical Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Orthopedic Surgical Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Orthopedic Surgical Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Orthopedic Surgical Devices Market: Ambulatory and Physician-Owned Facility Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Orthopedic Surgical Devices Market: Regional Snapshot, 2025
TABLE 80: Segment Dashboard; Definition and Scope, by Region
TABLE 81: U.S. Orthopedic Surgical Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 82: U.S. Orthopedic Surgical Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 83: West Region U.S. Orthopedic Surgical Devices Market: Regional Overview and Trends
TABLE 84: West Region U.S. Orthopedic Surgical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 85: West Region U.S. Orthopedic Surgical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 90: West Region U.S. Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 91: California Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 92: California Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 93: California Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 94: California Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 95: California Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 96: Washington Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 97: Washington Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 98: Washington Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 99: Washington Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 100: Washington Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 101: Arizona Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 102: Arizona Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 103: Arizona Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: Arizona Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 105: Arizona Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 106: Colorado Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 107: Colorado Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 108: Colorado Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 109: Colorado Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 110: Colorado Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 111: Oregon Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 112: Oregon Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 113: Oregon Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: Oregon Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 115: Oregon Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 116: Utah Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 117: Utah Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 118: Utah Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Utah Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 120: Utah Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 121: Nevada Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 122: Nevada Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 123: Nevada Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 124: Nevada Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 125: Nevada Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 130: New Mexico Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 131: Idaho Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 132: Idaho Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 133: Idaho Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: Idaho Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 135: Idaho Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 136: Montana Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 137: Montana Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 138: Montana Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 139: Montana Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 140: Montana Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 145: Wyoming Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 146: Alaska Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 147: Alaska Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 148: Alaska Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 149: Alaska Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 150: Alaska Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 155: Hawaii Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 156: Northeast Region U.S. Orthopedic Surgical Devices Market: Regional Overview and Trends
TABLE 157: Northeast Region U.S. Orthopedic Surgical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 158: Northeast Region U.S. Orthopedic Surgical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 164: New York Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 165: New York Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 166: New York Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 167: New York Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 168: New York Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 173: Massachusetts Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 178: New Jersey Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 183: Pennsylvania Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 188: Connecticut Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 189: Maine Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 190: Maine Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 191: Maine Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 192: Maine Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 193: Maine Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 194: Vermont Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 195: Vermont Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 196: Vermont Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 197: Vermont Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 198: Vermont Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 203: New Hampshire Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 208: Rhode Island Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 209: Delaware Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 210: Delaware Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 211: Delaware Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 212: Delaware Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 213: Delaware Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 214: South Region U.S. Orthopedic Surgical Devices Market: Regional Overview and Trends
TABLE 215: South Region U.S. Orthopedic Surgical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 216: South Region U.S. Orthopedic Surgical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 222: Texas Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 223: Texas Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 224: Texas Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 225: Texas Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 226: Texas Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 227: Florida Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 228: Florida Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 229: Florida Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 230: Florida Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 231: Florida Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 232: Georgia Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 233: Georgia Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 234: Georgia Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 235: Georgia Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 236: Georgia Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 241: North Carolina Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 246: Tennessee Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 251: South Carolina Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 252: Alabama Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 253: Alabama Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 254: Alabama Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 255: Alabama Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 256: Alabama Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 261: Mississippi Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 266: Louisiana Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 271: Arkansas Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 276: Kentucky Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 281: Oklahoma Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 282: Virginia Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 283: Virginia Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 284: Virginia Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 285: Virginia Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 286: Virginia Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 287: Maryland Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 288: Maryland Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 289: Maryland Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 290: Maryland Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 291: Maryland Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 296: West Virginia Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 297: Midwest Region U.S. Orthopedic Surgical Devices Market: Regional Overview and Trends
TABLE 298: Midwest Region U.S. Orthopedic Surgical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 299: Midwest Region U.S. Orthopedic Surgical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 300: Midwest Region U.S. Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 305: Illinois Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 306: Illinois Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 307: Illinois Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 308: Illinois Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 309: Illinois Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 310: Ohio Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 311: Ohio Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 312: Ohio Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 313: Ohio Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 314: Ohio Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 315: Michigan Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 316: Michigan Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 317: Michigan Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 318: Michigan Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 319: Michigan Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 320: Minnesota Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 324: Minnesota Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 325: Indiana Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 326: Indiana Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 327: Indiana Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 328: Indiana Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 329: Indiana Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 330: Wisconsin Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 334: Wisconsin Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 335: Missouri Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 336: Missouri Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 337: Missouri Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 338: Missouri Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 339: Missouri Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 340: Iowa Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 341: Iowa Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 342: Iowa Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 343: Iowa Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 344: Iowa Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 345: Kansas Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 346: Kansas Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 347: Kansas Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 348: Kansas Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 349: Kansas Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 350: Nebraska Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 354: Nebraska Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 355: North Dakota Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 359: North Dakota Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 360: South Dakota Orthopedic Surgical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Orthopedic Surgical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Orthopedic Surgical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Orthopedic Surgical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 364: South Dakota Orthopedic Surgical Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 365: U.S. Orthopedic Surgical Devices Market: Competitive Landscape Snapshot, 2025
TABLE 366: U.S. Orthopedic Surgical Devices Market: Key Company Market Share Analysis, 2025
TABLE 367: U.S. Orthopedic Surgical Devices Market: Company Positioning Matrix
TABLE 368: U.S. Orthopedic Surgical Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 369: U.S. Orthopedic Surgical Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 370: Stryker Corporation: Company Profile
TABLE 371: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 372: DePuy Synthes: Company Profile
TABLE 373: Medtronic: Company Profile
TABLE 374: Smith+Nephew: Company Profile
TABLE 375: Globus Medical, Inc.: Company Profile
TABLE 376: Arthrex, Inc.: Company Profile
TABLE 377: Enovis Corporation: Company Profile
TABLE 378: Integra LifeSciences Holdings Corporation: Company Profile
TABLE 379: CONMED Corporation: Company Profile
TABLE 380: Orthofix Medical Inc.: Company Profile
TABLE 381: Alphatec Holdings, Inc.: Company Profile
TABLE 382: B. Braun Aesculap: Company Profile
TABLE 383: MicroPort Orthopedics Inc.: Company Profile
TABLE 384: Exactech, Inc.: Company Profile
TABLE 385: Acumed LLC: Company Profile
TABLE 386: restor3d, Inc.: Company Profile
TABLE 387: SI-BONE, Inc.: Company Profile
TABLE 388: Treace Medical Concepts, Inc.: Company Profile
TABLE 389: Anika Therapeutics, Inc.: Company Profile
TABLE 390: Bioventus Inc.: Company Profile
TABLE 391: Colson Medical, LLC: Company Profile
TABLE 392: Aspen Surgical Products, Inc.: Company Profile
TABLE 393: Medacta International: Company Profile
TABLE 394: OSSIO Ltd.: Company Profile
TABLE 395: U.S. Orthopedic Surgical Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 396: U.S. Orthopedic Surgical Devices Market: Disruptive Technologies Impact Matrix
TABLE 397: U.S. Orthopedic Surgical Devices Market: Emerging Business Trends
TABLE 398: U.S. Orthopedic Surgical Devices Market: Business Opportunities for Startups and Existing Players
TABLE 399: U.S. Orthopedic Surgical Devices Market: Investment Prioritization Matrix
TABLE 400: U.S. Orthopedic Surgical Devices Market: Strategic Recommendations for Orthopedic Device Manufacturers
TABLE 401: U.S. Orthopedic Surgical Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 402: U.S. Orthopedic Surgical Devices Market: Strategic Recommendations for Orthopedic Specialty Hospitals
TABLE 403: U.S. Orthopedic Surgical Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 404: U.S. Orthopedic Surgical Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 405: U.S. Orthopedic Surgical Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 406: U.S. Orthopedic Surgical Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 407: U.S. Orthopedic Surgical Devices Market: Go-to-Market Strategy Considerations
TABLE 408: U.S. Orthopedic Surgical Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 409: U.S. Orthopedic Surgical Devices Market: Scope Limitation
TABLE 410: U.S. Orthopedic Surgical Devices Market: Data Use Limitation
TABLE 411: U.S. Orthopedic Surgical Devices Market: Forecasting Limitation
TABLE 412: U.S. Orthopedic Surgical Devices Market: Legal Disclaimer
TABLE 413: U.S. Orthopedic Surgical Devices Market: Third-Party Data Disclaimer
TABLE 414: U.S. Orthopedic Surgical Devices Market: Market Estimation and Assumption Disclaimer
TABLE 415: U.S. Orthopedic Surgical Devices Market: Company and Product Information Disclaimer
TABLE 416: U.S. Orthopedic Surgical Devices Market: Regulatory and Reimbursement Information Disclaimer

List of Figures

FIGURE 1: U.S. Orthopedic Surgical Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Orthopedic Surgical Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Orthopedic Surgical Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Joint Reconstruction Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Spinal Surgery Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Trauma and Fracture Fixation Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Sports Medicine and Arthroscopy Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Orthobiologics and Bone-Graft Products Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Orthopedic Surgical Instruments, Power Tools, and Enabling Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Osteoarthritis and Degenerative Joint Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Spinal Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Trauma and Fragility Fractures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Sports Injuries and Soft-Tissue Repair Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Extremity and Complex Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 31: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Orthopedic Specialty Hospitals and Centers of Excellence Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Trauma and Emergency Care Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Academic Medical Centers and Teaching Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 38: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Conventional Implant and Instrument Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Computer-Assisted Navigation Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Robotic-Assisted Orthopedic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Three-Dimensional Printed and Patient-Specific Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: AI-Enabled, Connected, and Data-Driven Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 45: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Ambulatory and Physician-Owned Facility Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 52: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: West Region U.S. Orthopedic Surgical Devices Market Share and Leading Players, 2025
FIGURE 54: West Region Market Share Analysis by State, 2025
FIGURE 55: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: California Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Washington Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Arizona Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Colorado Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Oregon Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Utah Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Nevada Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: New Mexico Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Idaho Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Montana Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Wyoming Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Alaska Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Hawaii Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Northeast Region U.S. Orthopedic Surgical Devices Market Share and Leading Players, 2025
FIGURE 70: Northeast Region Market Share Analysis by State, 2025
FIGURE 71: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: New York Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Massachusetts Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: New Jersey Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Pennsylvania Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Connecticut Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Maine Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Vermont Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New Hampshire Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Rhode Island Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Delaware Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: South Region U.S. Orthopedic Surgical Devices Market Share and Leading Players, 2025
FIGURE 83: South Region Market Share Analysis by State, 2025
FIGURE 84: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Texas Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Florida Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Georgia Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: North Carolina Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Tennessee Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: South Carolina Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Alabama Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Mississippi Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Louisiana Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Arkansas Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Kentucky Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Oklahoma Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Virginia Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Maryland Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: West Virginia Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Midwest Region U.S. Orthopedic Surgical Devices Market Share and Leading Players, 2025
FIGURE 101: Midwest Region Market Share Analysis by State, 2025
FIGURE 102: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Illinois Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Ohio Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Michigan Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Minnesota Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Indiana Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Wisconsin Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Missouri Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Iowa Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Kansas Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Nebraska Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: North Dakota Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: South Dakota Orthopedic Surgical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 116: Company Positioning Matrix
FIGURE 117: Key Player Product Portfolio Benchmarking
FIGURE 118: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 119: Orthopedic Surgical Device Innovation Roadmap
FIGURE 120: Robotic-Assisted Joint Reconstruction Adoption Roadmap
FIGURE 121: Robotic and Navigation-Guided Spine Surgery Opportunity Map
FIGURE 122: Three-Dimensional Printed and Patient-Specific Implant Roadmap
FIGURE 123: Outpatient Orthopedic Surgery Growth Roadmap
FIGURE 124: Future Market Scenario Analysis, 2026–2035
FIGURE 125: Disruptive Technologies Impact Matrix
FIGURE 126: Emerging Business Trends Matrix
FIGURE 127: Investment Prioritization Matrix
FIGURE 128: Strategic Growth Roadmap for U.S. Orthopedic Surgical Device Companies
FIGURE 129: Go-to-Market Strategy Framework
FIGURE 130: Product Positioning and Portfolio Expansion Framework
FIGURE 131: Report Scope and Disclaimer Framework